119 related articles for article (PubMed ID: 3393979)
21. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
22. [Remote afterloading high dose rate intracavitary therapy in carcinoma of the uterine cervix].
Monzen Y; Ajimu A; Yamada K; Yoshida S; Hayashi N; Morikawa M; Ashizawa K; Hayashi K; Honbo Z
Rinsho Hoshasen; 1988 Nov; 33(12):1565-8. PubMed ID: 3221475
[No Abstract] [Full Text] [Related]
23. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
[TBL] [Abstract][Full Text] [Related]
24. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
[TBL] [Abstract][Full Text] [Related]
25. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
[TBL] [Abstract][Full Text] [Related]
26. Modified instrumentation to minimize radiation side effects in treatment of cervix cancer with afterloading system Buchler.
Uchiyama G; Saito Y; Akiyama S
Sonderb Strahlenther Onkol; 1988; 82():177-9. PubMed ID: 3134715
[No Abstract] [Full Text] [Related]
27. [Long-term results of 60Co HDR after-loading in the treatment of cervical cancer].
Wang XE
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):114-7. PubMed ID: 8223119
[TBL] [Abstract][Full Text] [Related]
28. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
29. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
30. [Developments in brachytherapy].
Ikeda H
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1317-23. PubMed ID: 7668864
[TBL] [Abstract][Full Text] [Related]
31. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
[TBL] [Abstract][Full Text] [Related]
32. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
[TBL] [Abstract][Full Text] [Related]
33. Technique and individual afterloading treatment planning simulating classic Stockholm brachytherapy for cervix cancer.
Löffler E; van der Laarse R
Sonderb Strahlenther Onkol; 1988; 82():83-9. PubMed ID: 3394008
[No Abstract] [Full Text] [Related]
34. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
[TBL] [Abstract][Full Text] [Related]
35. [A prospective randomized study on the fractionation of afterloading therapy of cancer of the cervix and endometrium].
Kob D; Kloetzer KH; Kriester A; Sommer H
Strahlenther Onkol; 1988 Dec; 164(12):708-13. PubMed ID: 3061042
[TBL] [Abstract][Full Text] [Related]
36. Present status of brachytherapy, especially HDR afterloading in Japan.
Morita K; Uchiyama Y
Sonderb Strahlenther Onkol; 1988; 82():16-21. PubMed ID: 3134712
[No Abstract] [Full Text] [Related]
37. [Preoperative low-dose-rate versus high-dose-rate brachytherapy in stage IB cervix cancer. An efficacy study].
Mayer A; Nemeth G; Nemeskeri C; Thalacker U
Strahlenther Onkol; 1993 Dec; 169(12):716-20. PubMed ID: 8284743
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
[TBL] [Abstract][Full Text] [Related]
39. [Locally advanced carcinoma of the cervix (distal II, Barrel-shaped and III) treated by irradiation alone: impact of individual treatment planning on results, sequelae and complications].
Barillot I; Horiot JC; Maingon P; Bône-Lepinoy MC; D'Hombres A; Comte J
Bull Cancer Radiother; 1996; 83(4):364-9. PubMed ID: 9081339
[No Abstract] [Full Text] [Related]
40. Dose rate definition with microSelectron-HDR and Selectron-MDR in brachytherapy for carcinoma of the cervix.
el-Baradie MM; Fournier-Bidoz N; Inoue T; Inoue T; Yamazaki H
Anticancer Res; 1998; 18(3B):2069-76. PubMed ID: 9677469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
